HHE Haematology supplement 2018 - Page 3

Contents Editor – Secondary Care Andrea Porter Art Editor James Depree Commercial Director – Secondary Care Greg Damalis Published in the UK by Cogora Limited. 140 London Wall London EC2Y 5DN. Printed in the UK by Alban House Print Services, London. ISSN 1479-1927. ISBN 978-1-904471-97-4. Copyright © Cogora Ltd August 2018. The contents of this publication are protected by copyright. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means without the written permission of the ­publisher. The views expressed in this publication are not necessarily those of the publisher or production team. While the publisher and production team have taken every care with regard to accuracy of editorial and advertisement contributions, they cannot be held responsible for any errors or omissions contained therein. Additional copies of this book are available for sale, while stocks last, at £165 per copy, including postage and packaging contact: circulation@hospitalhealth care.com 5 Targeting optimal care, together Umberto Ricardi 7 Anti-GD2 mAbs for the treatment of high-risk neuroblastoma Jaume Mora 13 Evolving protection in haemophilia Swedish Orphan Biovitrum 17 Oral anticoagulants and cancer-associated thrombosis Guy Meyer 19 CAR T-cell therapy: managing side effects Tiene Bauters 22 Perspectives for treating cancer-associated thrombosis Paolo Prandoni and Andrea Piccioli 24 Implications of licensed standardised chemotherapy doses and their potential impact Tariro Kabba and Christopher Woodard 7 3 HHE 2018 | hospitalhealthcare.com